INS and diabetes mellitus: Recently, researchers constructed an engineered commensal bacteria which could express full-length form of GLP-1 (1-37), and they found the strain could be taken orally to improve diabetes because the intestinal cells were reprogrammed as glucose-reactive insulin-secreting cells (Duan et al., 2015).